TCG Crossover Management

TCG Crossover Management as of March 31, 2022

Portfolio Holdings for TCG Crossover Management

TCG Crossover Management holds 20 positions in its portfolio as reported in the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Iveric Bio Common Stock 17.0 $42M 2.5M 16.83
Viridian Therapeutics Common Stock (VRDN) 9.8 $24M 1.3M 18.49
Cogent Biosciences Common Stock (COGT) 9.0 $22M 3.0M 7.49
Aclaris Therapeuitics Common Stock (ACRS) 7.9 $20M 1.1M 17.24
Geron Corporation Common Stock (GERN) 7.8 $19M 14M 1.36
CymaBay Therapeutics Common Stock 7.4 $18M 5.9M 3.11
Aerovate Therapeutics Common Stock (AVTE) 6.5 $16M 890k 18.33
Chinook Therapeutics Common Stock 5.8 $14M 882k 16.36
Tyra Biosciences Common Stock (TYRA) 3.9 $9.6M 896k 10.70
Tango Therapeutics Common Stock (TNGX) 3.8 $9.5M 1.3M 7.58
Alpine Immune Sciences Common Stock 3.7 $9.3M 1.0M 8.97
Kura Oncology Common Stock (KURA) 3.3 $8.1M 506k 16.08
Merus Common Stock (MRUS) 3.2 $7.9M 300k 26.44
Akouos Common Stock 2.6 $6.4M 1.4M 4.75
Magenta Therapeutics Common Stock 2.5 $6.2M 2.1M 2.90
Entrada Therapeutics Common Stock (TRDA) 2.5 $6.1M 664k 9.24
Zai Lab LTD- Common Stock (ZLAB) 1.7 $4.2M 95k 43.98
Pardes Biosciences Common Stock 0.7 $1.7M 229k 7.22
AnaptysBio Common Stock (ANAB) 0.6 $1.4M 59k 24.75
Elevation Oncology Common Stock (ELEV) 0.6 $1.4M 555k 2.52